Skip to content
Cash Flow Statement · TASI 7020

Etihad Etisalat Company (Mobily)
Cash and cash equivalents at period end history.

Cash and cash equivalents at the end of each reporting period. Explore 23 reported observations from 2017 to 2026, with every value linked to its official evidence.

Coverage2017–202623 source-linked periods
Annual history5annual reporting periods
Interim history18quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2025HISTORICALCash and cash equivalents at period end3.16B SAR
Cash and cash equivalents at period end01B2B3B4B201720182019202020212022202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents at period end3.11B SAR
Cash and cash equivalents at period end01B2B3B4B202120222023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents at period end2.88B SAR
Cash and cash equivalents at period end01B2B3B202120222023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents at period end2.73B SAR
Cash and cash equivalents at period end01B2B3B202120222023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-302,730,158Nine months ended 30 September 2026 · thousands2.73B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
H1 / Q2 20262026-06-302,878,187Six months ended 30 June 2026 · thousands2.88B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
Q1 20262026-03-313,107,751Three months ended 31 March 2026 · thousands3.11B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
FY 20252025-12-313,161,691Year ended 31 December 2025 · thousands3.16B SARCash and cash equivalents at end of the yearNote 18Official p. 13 ↗Open statement →
9M / Q3 20252025-09-301,934,923Nine months ended 30 September 2025 · thousands1.93B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
H1 / Q2 20252025-06-302,240,009Six months ended 30 June 2025 · thousands2.24B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
Q1 20252025-03-311,485,312Three months ended 31 March 2025 · thousands1.49B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Open statement →
FY 20242024-12-311,399,542Year ended 31 December 2024 · thousands1.4B SARCash and cash equivalents at end of the yearNote 18Official p. 13 ↗Open statement →
9M / Q3 20242024-09-301,832,722Nine months ended 30 September 2024 · SAR’0001.83B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Saudi Exchange filing ↗Open statement →
H1 / Q2 20242024-06-302,227,573Six months ended 30 June 2024 · SAR’0002.23B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Saudi Exchange filing ↗Open statement →
Q1 20242024-03-311,612,162Three months ended 31 March 2024 · SAR’0001.61B SARCash and cash equivalents at end of the periodOfficial p. 8 ↗Saudi Exchange filing ↗Open statement →
FY 20232023-12-311,654,378Year ended 31 December 2023 · thousands1.65B SARCash and cash equivalents at end of the yearNote 18Official p. 13 ↗Open statement →
9M / Q3 20232023-09-30546,806Nine months ended 30 September 2023 · SAR’000546.81M SARCash and cash equivalents at end of periodOfficial p. 8 ↗Open statement →
H1 / Q2 20232023-06-30816,542Six months ended 30 June 2023 · SAR’000816.54M SARCash and cash equivalents at end of periodOfficial p. 8 ↗Open statement →
Q1 20232023-03-311,101,461Three months ended 31 March 2023 · SAR’0001.1B SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
FY 20222022-12-31827,725Year ended 31 December 2022 · thousands827.73M SARCash and cash equivalents at end of the yearNote 18Official p. 11 ↗Open statement →
9M / Q3 20222022-09-301,228,224Nine months ended 30 September 2022 · SAR’0001.23B SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
H1 / Q2 20222022-06-30843,644Six months ended 30 June 2022 · SAR’000843.64M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
Q1 20222022-03-31726,636Three months ended 31 March 2022 · SAR’000726.64M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
9M / Q3 20212021-09-30905,157Nine months ended 30 September 2021 · SAR’000905.16M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
H1 / Q2 20212021-06-301,188,447Six months ended 30 June 2021 · SAR’0001.19B SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
Q1 20212021-03-311,286,662Three months ended 31 March 2021 · SAR’0001.29B SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
FY 20172017-12-311,192,181Year ended 31 December 2017 · thousands1.19B SARCash and cash equivalents at the end of the yearNote 15Official p. 13 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

موبايلي — Cash and cash equivalents at period end

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.